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Abstract
Campylobacter infections are a major cause of diarrhoea world-wide and two of the antimi-
crobials used for their control (erythromycin and ciprofloxacin) have been losing efficacy in
recent years. In a sample of 174 genotyped isolates from the stools of patients with severe
diarrhoea in Qatar, collected between 2005 and 2012, 63.2% showed resistance to cipro-
floxacin, 8.6% to erythromycin, 0.57% to chloramphenicol and all were sensitive to genta-
mycin. While 33.9% of isolates were sensitive to all four antimicrobials, 59.8% were
resistant to at least one, 6.3% were resistant to two and none showed resistance to three
antimicrobials. There was no host sex- or age-dependence among isolates resistant to cip-
rofloxacin and erythromycin and no significant variation was found with the region of origin
of the patients. All isolates were screened for the presence of 3 virulence factors (ciaB,
cadF and cdtB) and two stress-response factors (htrB and clpP), all of which were present
in more than 50% of the isolates. Host sex-, age- and region of origin-dependent variations
in prevalence were found for some of these factors. Data analysis for the combination of vir-
ulence factors and their effect on antimicrobial resistance indicated that the prevalence of
resistance to both erythromycin and ciprofloxacin was higher in isolates harbouring ciaB but
not clpP. Prevalence of resistance to ciprofloxacin was similar in clpP positive and negative
isolates also possessing htrB, while for htrB-negative isolates prevalence was higher in the
absence of clpP. These results are discussed and their implications are highlighted.
Introduction
Campylobacter spp. are the leading cause of bacterial gastroenteritis worldwide [1]. These zoo-
notic bacteria can colonize humans with a relatively low infective dose and have potentially
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life-threating sequelae. Campylobacter spp. are suspected of causing disease via several mecha-
nisms such as cytotoxin production, intestinal cell invasion, and adherence and translocation.
The production of cytotoxin after intestinal colonization by ingested organisms arrests the cel-
lular cycle, ultimately leading to cell death and thereby inducing diarrhoea [2]. The ability to
invade intestinal cells results in damage to the mucosal surface cells of the jejunum, ileum and
colon [3]. Finally, Campylobacter has been reported to translocate extra-intestinally, crossing
the epithelium and gaining access to other parts of the body [4].
The drug of choice for the treatment of human Campylobacter infections is erythromycin
(member of the macrolide family), followed by ciprofloxacin (fluoroquinolone family) and tet-
racycline [5], however, a dramatic increase in Campylobacter jejuni resistance to fluoroquino-
lones has been observed in the USA since the mid-1990s [5]. Initially, during the period of
1982–1992, no isolates of C. jejuni showed resistance to fluoroquinolone, and only 2% were
found to be resistant to erythromycin among 142 patients [5]. By 2001, resistance to fluoro-
quinolone had developed, and was widespread (40.5% among 47 C. jejuni isolates) [5]. This
rise of resistance to fluoroquinolone in human C. jejuni isolates has been linked to the licensing
of fluoroquinolone use in poultry production [6]. Enrofloxacin, a related fluoroquinolone, was
licensed in the early 1990s in Europe and Asia, and soon afterwards a high incidence of resis-
tant C. jejuni isolates was reported from animal sources, for example from Spain (99% C. jejuni
isolated from broiler farms), while 72% of human isolates were found to show resistance in the
same period [7]. A similar trend was observed in Taiwan, where 92% of C. jejuni isolated from
chickens and 52% of human isolates were found to be resistant to fluoroquinolones by 1998–
2008 [8,9]. Fluoroquinolones are just one example, as increased antimicrobial resistance has
been documented also for other commonly used antimicrobials, including clindamycin, eryth-
romycin, streptomycin, and tetracycline [10].
Several mechanisms for antimicrobial resistance have been suggested for Campylobacter dif-
fering between the drugs involved. For fluoroquinolones the main resistance mechanism is
probably a mutation in the gyrA gene, which encodes part of the DNA gyrase [11], while tetra-
cycline resistance is thought to be typically mediated through the tetO gene [12,13]. For macro-
lides, a mutation in the target ribosome binding site mediates resistance [14]. Compared with
infection by antimicrobial-susceptible strains, antimicrobial-resistant strains of Campylobacter
have been reported to be associated with a longer duration of clinical symptoms [15,16]. Cipro-
floxacin-resistant C. jejuni strains colonize poultry intestinal tracts better than isogenic suscep-
tible C. jejuni strains even in the absence of fluoroquinolone selection pressure [17], indicating
an association between resistance and the ability to colonize.
In addition, several genes have been linked to enhanced virulence of Campylobacter but the
most important ones are Campylobacter invasion protein B (ciaB), cytolethal distending toxin
B (cdtB) which disrupts mucosal barriers by causing host cell death, Campylobacter adhesin to
fibronectin F (cadF), and the heat survival and stress-response proteins htrB and clpP. It is
well-documented that there is an association between certain Campylobacter virulence genes
and the pattern of clinical infection [18,19]. However, virulence may also be involved in modu-
lating the expression of resistance to antimicrobial agents and such an association of antimicro-
bial resistance with virulence genes has already been noted in bacterial pathogens including
Escherichia coli and Enterococcus faecalis [20,21] but not yet for Campylobacter.
To our knowledge, no data are available from Qatar regarding the status of antimicrobial re-
sistance in Campylobacter. Herein, we first analyzed a nine-year dataset from the HamadMedi-
cal Corporation (HMC) from which we extracted prevalence data on the most common enteric
bacterial pathogens encountered in recent years in the stools of subjects with severe bloody di-
arrhoea in Qatar, in order to assess the relative importance of Campylobacter in the local popu-
lation. We then investigated the prevalence and association of antimicrobial resistance and
Analysis of Campylobacter from Patients with Diarrhoea
PLOS ONE | DOI:10.1371/journal.pone.0119268 March 17, 2015 2 / 16
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
several virulence factors among C. jejuni isolates from symptomatic patients presenting as out-
patients at the HMC hospital in order to enable knowledge based informed decisions relevant
to the continuously changing dynamics of this society to be made by local health professionals
and policy makers [22].
Materials and Methods
Clinical specimens
Ethical approval was obtained by Hamad Medical Corporation, Medical Research Center (Re-
search protocol #13334/13). Consent was not required as the data were analyzed anonymously.
All outpatients with severe and bloody diarrhoea are routinely screened at the HMC hospital
for the presence of enteric bacteria using U.K. standards for microbiology investigations [23].
As part of the current work, data on the number of subjects screened and positives for each
infectious agent were made available for the period 2005 to 2013, and these data are presented
as prevalence values, in order to show the relative frequencies of enteric bacteria among sub-
jects with severe diarrhoea in Qatar.
Further work, however, focused on Campylobacter. For this we exploited 216 cryopreserved
(−80°C) specimens from earlier years as well as across the period for which we have presented
prevalence values. Although we attempted to grow the bacterium from all 216 specimens
known to be positive for Campylobacter, only 174 (n = 101 for 2005 to 2008 and n = 73 for
2009 to 2012) produced colonies of bacteria that could be genotyped and assessed for sensitivi-
ty to antimicrobials.
Specimens were tested for the presence of Campylobacter spp. using standard culturing tech-
niques [24]. Specimens were streaked directly on Campyfix media supplemented with Skirrow
Campylobacter selective antibiotic mixture (Oxiod) and incubated at 42°C under microaerobic
conditions for 48 hours. The isolates were identified as C. jejuni based on the colony morpholo-
gy, catalase, oxidase, hippurate hydrolysis, and H2S (TSI) biochemical tests, in addition to resis-
tance to nalidixic acid and sensitivity towards cephalothin. A total of a 174 specimens
identified positive for C. jejuni were analyzed. DNA was extracted directly from bacterial cul-
ture using a Mericon DNA extraction (Qiagen) kit. Specimens were confirmed to be C. jejuni
by real-time PCR using a previously published primers/probe pair detecting the 16S rRNA
gene [25].
Presence of potential virulence factors genes in Campylobacter isolates
Real-time PCR was used to detect the presence of three of the most important Campylobacter
virulence factors. The genes are ciaB, cadF, and cdtB which are involved mainly in adhesion
and invasion [26]. Screening for another two genes that enhance the survival of the bacteria in
the environment and the host (htrB and clpP) was performed. These five genes will be referred
to as virulence factors from this point onwards. The primers (Table 1) were designed using
primer design software (Primer3) based on available sequences in GenBank. The primers were
tested on C. jejuni ATCC 33560 strain to confirm their efficiency. For each reaction, the follow-
ing conditions were used: A total of 7μl of Sybrselect (Life Technologies) master mixture was
used in each reaction along with 0.3μl primer mixture, 2.5μl specimen DNA, and 10.2μl molec-
ular grade water. RT-PCR cycles consisted of holding for 2 minutes at 95°C, followed by 40 cy-
cles at 95°C for 15 sec, 55°C for 35 sec, and 72°C for 1 minute. Initially, specimens having
positive Ct values were confirmed by agarose gel electrophoresis for each of the genes targeted
in this study. Specimens were run in duplicates.
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Testing for antimicrobial resistance
The susceptibility of each C. jejuni isolate to erythromycin, ciprofloxacin, gentamicin and chlor-
amphenicol was determined using the E-test (bioMerieux, Durham USA) and read after 24 hours
incubation in a microaerophilic environment at 42°C. TheMinimum Inhibitory Concentrations
(MIC) breakpoints of erythromycin (susceptible8μg/ml), and ciprofloxacin (susceptible1μg/
ml) were used as recommended by Clinical Laboratory Standards Institute approved guidelines
[27] for infrequently isolated or fastidious bacteria, and for gentamicin (susceptible4μg/ml)
and chloramphenicol (susceptible8μg/ml), as recommended for non-Enterobacteriaceae [28].
Statistical analysis
Throughout, data are presented as prevalence values (%) with 95% confidence limits (in col-
umns in tables, in parenthesis in the text and as error bars on figures), calculated as described
by Rohlf and Sokal [29], employing bespoke software. For sample sizes in excess of 1000 we
used the Poisson distribution if the number of positives was 100 or fewer, and for those over
100 we used the Gaussian distribution. All calculations were carried out on numbers based to
at least three decimal places, but are rounded to the nearest single decimal place or two decimal
places as relevant in the text and tables.
The first data-set used for analysis comprised 26,140 subjects screened for enteric bacteria.
These data were analysed using maximum likelihood on log-linear analysis of contingency ta-
bles, implemented in IBM-SPSS version 22, with YEAR (9 levels, corresponding to 2005 to
2013) and the presence/absence of each infectious agent in turn (INFECTION- present or ab-
sent) as a binary factor.
The second data-set comprised 174 isolates that were positive for Campylobacter and were
genotyped as well as assessed for sensitivity to each of the four antimicrobials used in the study.
These were derived from 104 male and 70 female subjects, for whom age was recorded in
months if under 1 year-old, and then in years for all older subjects. Most came from children
under three years of age (62.6%), and hence to allow analysis with age of host taken into con-
sideration, they were allocated to 5 age classes as follows: age class 1 = children less than 1 year-
old (for males n = 22, mean age 0.47; for females n = 12, mean age = 0.53); age class 2 = 1 year-
old children (for males n = 24, for females n = 20); age class 3 = 2 year-old children (for males
n = 21, for females n = 10); age class 4 = 3–12 year-old (for males n = 26, mean age = 5.2; for fe-
males n = 17, mean age = 6.7); age class 5 = 19–75 year-old (for males n = 11, mean age = 48.7;
for females n = 11, mean age = 40.6).
Table 1. Primers for virulence genes and stress response genes used in this study.
Genes Accession number Primers Sequence
cadF U87559.1 Forward 50- TAT GGT GTA GAA AAA AGT CGC ATC A-30
Reverse 50- ATC CGC TCT ACC TTC TTT AGT GTC A-30
cdtB CP008787.1 Forward 50- AAT GCA AGC TGA AGA AGT GAT TGT-30
Reverse 50- AGC ATC ATT TCC ATT GCG AAT-30
ciaB AF114831.1 Forward 50- CAA CTT TAT ATT TGC ACT CCG ATG-30
Reverse 50- GGA ACG ACT TGA GCT GAG AAT AAA C-30
clpP CP008787.1 Forward 50- TGG GAG CAT TTT TGC TTA GTT G-30
Reverse 50- CTC CAC CTA AAG GTT GAT GAA TCA T-30
htrB AL111168.1 Forward 50- CGC ACC CAA TTT GAC ATA GAA C-30
Reverse 50- TTT TTA GAG CGC TTA GCA TTT GTC T-30
doi:10.1371/journal.pone.0119268.t001
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The subjects were allocated to five geographical regions of origin because they came from 24
different countries as follows: Qatar (n = 72), Arabian Peninsula (total n = 33; Iran n = 7; Iraq
n = 1; Jordan n = 4; Oman n = 3; Palestine n = 7; Saudi Arabia n = 1; Syria n = 1; Yemen n = 9),
Asia (total n = 42; Afghanistan n = 1; Bangladesh n = 2; India n = 16; Indonesia n = 1; Pakistan
n = 20; Philippines n = 1; Sri Lanka n = 1), Africa (total n = 21; Egypt n = 11; Eritrea n = 1; Mo-
rocco n = 1; Sudan n = 6; Tunisia n = 2) and elsewhere (total n = 6; Canada n = 2; United King-
dom n = 1; United States n = 3).
For analysis of presence/absence of sensitivity to specific antimicrobials, and presence/ab-
sence of virulence factors we used maximum likelihood methods on log-linear analysis of con-
tingency tables with SEX (2 levels, male and female), AGE (5 age classes as detailed above),
REGION (region of origin at 5 levels as detailed above) and PRESENCE/ABSENCE of either
resistance to a specified antibiotic or of a specific virulence factor (binary factor). Full factorial
models were reduced to minimum sufficient models by step-wise deletion of non-significant
terms until only significant effects remained (backward selection procedure). All Chi-squared
values cited refer to these significant terms in minimum sufficient models, with all other rele-
vant factors taken into consideration.
In specific cases we also employed 2x2 and 2xn Chi-squared test to test specific hypotheses
as indicated in the text, using the methods described previously [30].
Results
Prevalence of enteric bacteria in stool specimens of outpatients with
diarrhoea
Fig. 1 shows the annual prevalence of pathogenic enteric bacteria in the period 2005 to 2013, in
26,140 subjects whose stools were examined because they had severe and bloody diarrhoea.
The prevalence of Salmonella was the highest across the whole period (8.6% [8.28–8.96]) but
there was significant variation between years (YEARINFECTION, χ28 = 161.2, P< 0.001).
Peak prevalence was recorded in 2006 and this was followed by a consistent decline over the
following years. E. coli (2.8% [2.64–3.04]), Shigella (2.8% [1.84–2.18]) and Campylobacter
(1.9% [1.73–2.06]) all showed lower but similar prevalence over the whole of this period, again
with some variation between years, which in all three cases was significant (χ28 = 94.9, 139.1
and 97.5, respectively and P<0.001 in all cases). As with Salmonella, there was a gradual decline
in cases in the later years of the period (Fig. 1). Across the whole period, 26 cases of Aeromonas,
7 of Vibrio, and 3 of Yersinia were also detected. A detailed breakdown of the number of cases
of Aeromonas, Campylobacter, E. coli, Salmonella, Shigella, Vibrio and Yersinia positive cases is
provided as supplementary information (See S1 Table).
Factors affecting resistance of Campylobacter to antimicrobials
Gentamycin and chloramphenicol. All specimens were sensitive to gentamycin and only
one specimen showed resistance to chloramphenicol (prevalence of resistance = 0.57% [0.052–
4.198]), so these were not analysed further, other than when the specimen that was resistant to
chloramphenicol was included in the analysis of multiple-drug resistance.
Ciprofloxacin. The most resistance was observed to ciprofloxacin (63.2% [54.02–71.63]),
and this was similar for isolates from both host sexes (Table 2), across all age classes (Table 2;
range 59.1% to 68.2%), and among isolates from subjects from the five regions (Table 2; range
57.6% to 72.1%). No significant effects were detected for the effect of SEX, AGE or REGION of
origin, or any interactions between these factors.
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Erythromycin. Resistance to erythromycin was rarer (8.6% [4.57–15.32]), also similar for
isolates from both sexes (Table 2) and across all five age classes (Table 2; range 7.0% to 11.8%).
Fig 1. Prevalence of enteric bacteria in the stools of outpatients reporting to the MHCwith severe diarrhoea in the period 2005–2013. The sample
sizes for 2005–2013 were 2220, 1916, 2460, 2394, 2528, 2726, 3347, 4373 and 4176, respectively.
doi:10.1371/journal.pone.0119268.g001
Table 2. The effect of host sex, age and country of origin on resistance of Campylobacter isolates to
antimicrobials.
Class Ciprofloxacin Erythromycin
n % 95% CL % 95% CL
Males 104 61.5 54.43–68.16 7.7 4.65–12.40
Females 70 65.7 54.14–75.91 10.0 4.82–19.14
Age class 1 34 64.7 49.84–77.54 11.8 4.92–24.50
Age class 2 44 59.1 41.97–74.63 6.8 1.53–20.36
Age class 3 31 67.7 53.55–79.82 9.7 3.77–21.51
Age class 4 43 60.5 43.58–75.58 7.0 1.65–20.37
Age class 5 22 68.2 45.35–84.82 9.1 1.64–29.07
Qatari 72 59.7 47.95–70.83 11.1 5.45–20.71
Arabian Peninsula 33 57.6 42.87–71.27 3.0 0.39–12.95
Asia 42 73.8 57.28–86.05 7.1 1.78–20.39
Africa 21 61.9 40.33–80.26 14.3 4.01–35.43
Elsewhere 6 66.7 27.14–93.71 0 0–41.13
doi:10.1371/journal.pone.0119268.t002
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However, there were some discrepancies between regions of origin of subjects (Table 2; 0% to
14.3%), but these were not significant.
Multiple drug resistance
While 33.9% [25.81–43.10] of specimens were sensitive to all four antimicrobials, 59.8%
[50.55–68.54] were resistant to at least one and 6.3% [3.07–12.27] were resistant to two. None
showed resistance to 3 or all four antimicrobials.
Factors affecting prevalence of virulence factors
All five virulence factors were present in more than 50% of specimens (Table 3). The most fre-
quent was cdtB and the least frequent cadF. Table 3 shows prevalence by geographic origin of
the hosts.
For ciaB there was a significant interaction between SEX and AGE on prevalence (χ24 =
10.8, P = 0.029), as illustrated in Fig. 2-A. The prevalence of ciaB increased with the age of
males, but among females prevalence was lower in age classes 3 and 4. There was no difference
between isolates from subjects from different regions.
The prevalence of cadF only differed between the sexes (males = 67.3% [60.24–73.68]; fe-
males = 48.6% [36.94–60.23];χ21 = 6.09, P = 0.014), and there was no effect of AGE or REGION
of origin (Table 3) and no interactions between these factors.
None of the factors affected the prevalence of cdtB among the specimens, but there was a
significant interaction between SEX and REGION of origin on the prevalence of htrB (Fig. 2-B;
χ24 = 10.7, P = 0.03). While in Qatar and the Arabian peninsula prevalence of htrB showed fe-
male bias, in Asia and Africa the bias was in favour of the male subjects.
The prevalence of clpP also varied markedly between sexes with a male bias (males = 89.4%
[84.24–93.20]; females = 74.3% [63.05–83.16];χ21 = 6.8, P = 0.009) and there was a significant in-
teraction between AGE and REGION (χ216 = 29.3, P = 0.022), which we did not explore further.
Relationship between virulence factors and resistance to ciprofloxacin
and erythromycin
Although the data in Table 4 show some bias in prevalence of virulence factors in some cases, none
of these were significant and therefore none of the virulence factors were clearly linked to resistance
to either drug. The nearest to significance was the discrepancy in the prevalence of htrB among
ciproxin sensitive and resistant isolates, for which there was a difference of 13.3% between resistant
isolates compared with those that were sensitive (Table 4). However, analysis revealed that this was
just the wrong side of the cut-off for significance, so this is indicative of a link but is not conclusive.
Table 3. Prevalence of virulence factors among isolates from subjects from different geographical regions and in the combined dataset.
Region of origin ciaB cadF cdtB htrB clpP
% 95% CL % 95% CL % 95% CL % 95% CL % 95% CL
Qatar 76.4 64.99–85.14 63.9 52.14–74.33 90.3 81.02–95.43 56.9 45.16–68.07 81.9 71.28–89.43
Arabian Peninsula 66.7 52.03–79.31 51.5 36.83–66.11 87.9 75.31–94.77 87.9 75.31–94.77 84.8 71.35–93.03
Asia 71.4 54.87–84.12 52.4 35.77–68.22 83.3 67.34–92.65 71.4 54.87–84.12 92.9 79.61–98.22
Africa 61.9 40.33–80.26 61.9 40.33–80.26 81.0 59.68–93.21 57.1 35.44–76.73 66.7 44.90–84.10
Elsewhere 83.3 41.14–99.14 100 58.87–100 100 58.87–100 100 58.87–100 83.3 41.14–99.14
Combined 71.8 62.98–79.36 59.8 50.55–68.54 87.4 80.12–92.48 67.8 58.64–75.80 83.3 75.34–89.21
doi:10.1371/journal.pone.0119268.t003
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Fig 2. Prevalence of the virulence factor ciaB (A) and htrB (B) amongmale and female subjects in
each of the age classes (A) and from each of the five regions of origin used for analysis (B). The
sample sizes in A were as follows: for the 104 male subjects, 22, 24, 21, 26 and 11, and for the 70 female
subjects 12, 20, 10, 17 and 11 for age classes 1–5 respectively in both cases. For the age span and average
age of each age class see Materials and Methods. The sample sizes in B were as follows: for the 104 male
subjects, 46, 18, 26, 11 and 3, and for the 70 female subjects 26, 15, 16, 10 and 3 for the five regions of origin
(Qatar, Arabian Peninsula, Asia, Africa and elsewhere) respectively in both cases. For further details of
countries of origin in each region see Materials and Methods.
doi:10.1371/journal.pone.0119268.g002
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Relationship between virulence factors and isolates of Campylobacter
showing sensitivity or resistance to 1 or 2 antimicrobials
Table 5 summarises the prevalence of each virulence factor among the isolates that were either
sensitive to any one or two of the antimicrobials. No isolate was resistant to three antimicrobial
and no significant effects were detected.
Combinations of virulence factors and their effects on resistance to
ciprofloxacin and erythromycin
We first examined pairwise combinations of the five virulence factors and their effects on resis-
tance to both antimicrobials. Of the ten possible combinations, in the case of erythromycin
prevalence of resistance was lower in those showing both factors compared with those with nei-
ther factor in eight out of ten cases, but the degree of reduction in prevalence of resistance ran-
ged only from −1.9% (ciaB and htrB) to −10.3% (cadF and htrB). In two cases prevalence of
Table 4. Prevalence of virulence factors among erythromycin sensitive and resistance isolates, and among ciprofloxacin sensitive and resistant
isolates.
Virulence factor Erythromycin Ciprofloxacin
Sensitive (n = 159) Resistant (n = 15) Sensitive (n = 64) Resistant (n = 110)
% 95% CL % 95% CL % 95% CL % 95% CL
ciaB 71.7 63.24–78.90 73.3 46.58–90.33 67.2 56.10–76.73 74.5 67.78–80.41
cadF 61.0 52.25–69.02 46.7 22.23–70.60 54.7 43.54–65.27 62.7 55.44–69.51
cdtB 88.1 81.26–92.69 80.0 53.43–94.31 89.1 80.12–94.49 86.4 80.64–90.73
htrB 69.2 60.55–76.73 53.3 29.40–77.77 59.4* 48.25–69.92 72.7 65.73–78.77
clpP 84.9 77.62–90.32 66.7 39.68–85.83 85.9 76.31–92.31 81.8 75.53–86.85
*2x2 Chi-squared test, χ21 = 3.3, P = 0.059
doi:10.1371/journal.pone.0119268.t004
Table 5. Prevalence of virulence markers among isolates which are sensitive or resistant to 1 or 2 antimicrobials.
Virulence factor Sensitive to all
antimicrobials (n = 59)
Resistant to 1
antimicrobials (n = 104)
Resistant to 2
antimicrobials (n = 11)
Statistical analysis
% 95% CL % 95% CL % 95% CL
ciaB +ve 67.8 57.11–76.98 73.1 66.27–78.96 81.8 50.00–96.66 χ22 = 0.82; P = 0.66 = NS
ciaB—ve 32.2 23.02–42.89 26.9 21.04–33.73 18.2 3.34–50.00
cadF +ve 55.9 45.19–66.13 62.5 55.39–69.13 54.5 26.46–80.04 χ22 = 0.742; P = 0.69 = NS
cadF-ve 44.1 33.87–54.81 37.5 30.87–44.61 45.5 19.96–73.54
cdtB +ve 89.8 81.58–94.80 86.5 80.99–90.78 81.8 50.00–96.66 χ22 = 0.44; P = 0.80 = NS
cdtB—ve 10.2 5.20–18.42 13.5 9.22–19.01 18.2 3.34–50.00
htrB +ve 61.0 50.30–70.76 72.1 65.28–78.06 63.6 33.29–86.49 χ22 = 2.16; P = 0.34 = NS
htrB—ve 39.0 29.24–49.70 27.9 21.94–34.72 36.4 13.51–66.71
clpP +ve 86.4 77.47–92.37 83.7 77.76–88.37 63.6 33.29–86.49 χ22 = 2.45; P = 0.25 = NS
clpP-ve 13.6 7.63–22.53 16.3 11.63–22.24 36.4 13.51–66.71
All statistical tests here were 2x3 Chi-squared tests
doi:10.1371/journal.pone.0119268.t005
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resistance was marginally higher in those isolates expressing both virulence factors (ciaB and
cdtB by 7.1%; ciaB and clpP by 5.4%), but in no case was the difference in prevalence of resis-
tance among isolates that were negative for both factors and those expressing both, significant.
Six combinations showed increased resistance to ciprofloxacin, ranging from 7.5% (cadF and
clpP) to 19.2% (cadF and htrB), the latter being just outside the cut-off for significance (2x2
Chi-squared test, χ21 = 3.47, P = 0.062). Four combinations showed lower resistance ranging
from −4.5% (ciaB and cdtB) to −15.7% (cdtB and clpP) and none were significant.
Analysis by fitting log-linear models indicated three significant interactions. Fig. 3-A shows
that prevalence of resistance to ciprofloxacin was very similar in ciaB negative isolates whether
they expressed clpP or not, while for ciaB positive isolates prevalence of resistance was higher
in the absence of clpP (χ21 = 5.2, P = 0.023). Fig. 3-B shows that while in clpP negative isolates
prevalence of resistance to ciprofloxacin was similar whether they expressed htrB or not,
among clpP positive isolates prevalence of resistance was higher when htrB was also present
(χ21 = 6.9, P = 0.002). Finally in Fig. 3-C it can be seen that among clpP negative isolates preva-
lence of resistance to erythromycin was higher in ciaB positive isolates, while in clpP positive
isolates prevalence of resistance was generally lower and only differed marginally between iso-
lates that were positive or negative for ciaB (χ21 = 9.5, P = 0.002).
Discussion
Diarrhoeal diseases remain a leading cause for morbidity and mortality worldwide despite ad-
vances in our understanding of pathogen transmission patterns. The nine-year dataset we ana-
lyzed from HMC for 26,140 subjects who presented with clinical gastrointestinal signs showed
that a group of bacterial pathogens are responsible for a significant proportion of these cases.
Indeed, Salmonella, Campylobacter, E. coli, or Shigella were involved collectively in at least 15%
of the cases. Prevalence of these pathogens varied over the years, with a clear decline in most
cases towards the end of the study period. This year-to-year variation in prevalence emphasizes
the importance of the surveillance program HMC is implementing to monitor this group of
pathogens. The analysis of the nine-year data set also confirmed the importance of C. jejuni as
a common enteric pathogen in Qatar.
As the next step in this study, we investigated the prevalence of antimicrobial resistance and
its association with the presence of virulence and environment stress response genes in C.
jejuni isolates from symptomatic individuals. As erythromycin is the drug of choice for the
treatment of C. jejuni, it was reassuring to find that antimicrobial resistance to this drug was
relatively low, as only 8.6% of the isolates were resistant. On the other hand, the relatively high
level of resistance to ciprofloxacin (63.2%), regardless of the country of origin of the patient, is
alarming as this fluoroquinolone is indicated for the treatment of a variety of critical infections
in adults [31]. Fluoroquinolones are considered critical drugs for the treatment of humans by
the World Health Organization and the veterinary fluoroquinolones, enrofloxacin and dano-
floxacin, are commonly used antimicrobial drugs in food-producing animals and are thought
to play a role in the spread of resistance to human isolates [32,33]. A high rate of resistance has
also been reported in the United Arab Emirates where 85.4% of isolates were resistant to this
antimicrobial [34], while isolates from other countries have shown lower rates of prevalence, e.
g. 40% in Poland and 2% in Australia were reported to be resistant [35,36]. As the use of fluoro-
quinolones in food-producing animals is permitted in the UAE and Qatar, while it is banned in
Australia, this difference in the levels of resistance could be attributable to the continued use of
these antimicrobials. Further assessment of the rate of antimicrobial resistance among C. jejuni
isolates from animals, in addition to concurrent genetic relationships, should determine if this
is truly the case in Qatar.
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As for the presence of virulence factors, all five factors investigated here were present in
more than 50% of the specimens, with cdtB being the most frequently encountered and cadF
the least. cadF is an adhesin and fibronectin-binding protein involved in the process of invasion
by inducing structural re-arrangement through microfilament manipulation [37]. Since all the
Fig 3. Prevalence of resistance to ciprofloxacin (A and B) and erythromycin (C) inCampylobacter
isolates which were positive or negative for the clpP virulence factor, in the presence/absence of
CiaB (A and C) and htrB (B). Sample sizes are given on the columns in A and B, and for C the sample sizes
were the same as in A.
doi:10.1371/journal.pone.0119268.g003
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Campylobacter isolates investigated here were obtained from symptomatic patients and only
59.8% carried this gene, it is likely that the presence or absence of this one gene is not enough
to set up infection or abolish it. The low prevalence of cadF contrasts with several other studies
that have found this virulence factor in nearly all of the Campylobacter isolates that were exam-
ined [38,39,40,41]. Campylobacter strains that have a cadF deletion mutation are unable to col-
onize in chickens and their internalization ability into INT 407 intestinal cells is compromised
[37]. However, clearly isolates in which we did not detect the gene survive in human subjects,
as evidenced in our study, but because of the methods employed here we cannot eliminate the
possibility that a variant of the gene, that was not detected by our PCR based methodology, was
present and capable of mediating invasion of the host (see below for further discussion). Never-
theless, there is no current information on any variants of this gene, with a different nucleotide
base sequence, that would not have been detected by our PCR primers.
The cytotoxin produced by C. jejuni can damage nuclear DNA, causing the cell cycle to ar-
rest in the G2 or M phase [42]. Cytolethal distending toxin is also involved in the production of
pro-inflammatory cytokines such as IL-8 from intestinal epithelial cells in vitro [43] which
might explain the role it plays in pathogenesis. Several studies have indicated that the preva-
lence of cdtB in isolates from poultry or humans exceeds 90% [41], which is in agreement with
our findings and was expected, given that the isolates studied here were all from clinical cases.
The ciaB gene is critical for invasion of epithelial cells as mutants lacking this gene are not
able to invade cell lines in vitro [44]. As C. jejuni lacks a type III secretion system, this protein
is secreted through a flagellar export system [45], but again in this study we did not detect ciaB
in 28.2% of the isolates studied. Although ciaB was shown to be important for invasion using
in vitro systems, in this study human isolates that lack this gene still caused clinical signs, indi-
cating that even in its absence C. jejuni can cause disease.
C. jejuni is likely to encounter a wide range of temperatures during a contamination cycle
and must therefore be able to adapt and respond to these temperatures. In contrast to other
foodborne pathogens, C. jejuni does not possess genes encoding cold-shock proteins such as
cspA which might explain why it cannot grow at low temperatures [1,46]. On the other hand,
C. jejuni utilizes heat-shock proteins, including the ATP-dependent proteases clpP, which re-
pair and prevent damage caused by accumulation of unfolded proteins [47,48]. Our study de-
tected an interesting interaction between the presence/absence of this stress response gene and
ciaB. In the case of resistance to both ciprofloxacin and erythromycin, isolates that did not ex-
press clpP, but were positive for ciaB, showed a higher prevalence of resistance. How the gene
products of these two genes interact to bring this interaction about is not known, but it is clear-
ly of interest if we are to achieve a comprehensive understanding of the mechanisms of the evo-
lution and maintenance of antimicrobial resistance in Campylobacter infections.
The C. jejuni htrB gene encodes an acyltransferase that contributes to lipid A synthesis
[49,50] and is conserved in C. jejuni. It is similar to the htrB gene of Salmonella typhimurium,
E. coli andHaemophilus influenzae. The high prevalence of this gene in this group of clinical
specimens might indicate its importance for the survival of this bacterium inside the host, but,
nevertheless a proportion (32.2%) of our isolates did not express this gene, and here also we de-
tected an interaction with clpP on prevalence of resistance to ciprofloxacin. While htrB positive
isolates showed similar prevalence of resistance irrespective of whether they expressed clpP or
not, among htrB negative isolates resistance was higher in the absence of clpP. Again, this sug-
gests complex underlying background genetic and epistatic interactions.
Whilst we did not find any evidence of significant variation in the extent of resistance to cip-
rofloxacin or erythromycin that was host age-, sex- or region of origin-dependent, we did find
that the presence of some of the virulence and stress factors on isolates was dependent on these
host factors. For example, the prevalence of isolates expressing ciaB increased with the age in
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male subjects, but among females the prevalence was lower in subjects aged 2–12 year-old. A
sex effect was also noticed for cadF which was more prevalent in males than females. As cadF is
involved in adhesion to the intestinal wall of the host while ciaB is thought to be involved in
cellular invasion of Campylobacter, it is likely that the different sex and age effects are linked to
the different habitats for the bacteria in hosts of varying age and sex. Moreover, these sex- and
age-linked effects on the expression of virulence/stress factors may in part explain the known
predominance of Campylobacter among male subjects, which has been attributed to physiolog-
ical differences between the sexes [51].
Although the findings in this study show a high prevalence of some of the virulence factors
investigated, such as cdtB and ciaB, it is important to emphasize that the presence or absence of
these genes is indicative, but may not predict precisely how virulent a particular Campylobacter
isolate may be in vivo and further studies have to be carried out to reach a definitive conclusion.
As already intimated above, it is also important to be aware that a negative result by RT-PCR
could be attributed not just to an absence of the gene in question but possibly also to sequence
variation at the primer binding site, perhaps indicating a variant of the same molecule with ei-
ther identical or perhaps different biological activity. This is an important limitation of the mo-
lecular methods employed here, relying entirely on the amplification of the targeted region,
and therefore the data should be interpreted carefully.
Positive and negative associations between virulence genes and antimicrobial resistance
have been found in several bacterial pathogens including E. coli and E. faecalis [21,52]. A muta-
tion in the gyrA gene in C. jejuni on the other hand enhances its ability to colonize chickens
and therefore survival [17]. Another clear example is the effect of streptomycin resistance on
the growth of Salmonella, as resistant strains have poor growth on rich media because they can-
not express the rpoS gene which is important for regulation of environmental stress responses
[53]. As the presence of antimicrobial resistance and potential virulence factors are both im-
portant in their own right, further investigation of the basis of synergistic and antagonistic in-
teractions between their presence/absence in clinical isolates might provide new insight into
the nature of Campylobacter pathogenesis. Indeed, methicillin resistance of Staphylococci, for
example, has been used over the years as a marker to classify the different isolates as it is a criti-
cal factor in predicting not only the outcome of infection but also the fitness level of the isolate
[54]. As for E. coli, a positive relationship has been established between multiple drug resistance
and the severity and duration of clinical symptoms [55].
Finally, in this study we have provided for the first time data on the prevalence of resistance
to two of the most popular and widely used antimicrobials for the treatment of Campylobacter,
among isolates of this bacterium from subjects in Qatar. We have also quantified the frequency
of five key virulence factors and detected some interactions between these and the expression
of antimicrobial resistance. The exact nature of the underling mechanisms and the significance
of these effects and their various interactions for the adaptability of C. jejuni is not yet clear. In
view of the importance of Campylobacter as a disease causing organism in humans, and its fre-
quent occurrence among the Qatari population, further work is warranted urgently and we
hope to have provided here a springboard for such research in the years ahead.
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